Search Results - "Simona, Barlera"

Declining Risk of Sudden Death in Heart Failure by Shen, Li, Jhund, Pardeep S, Petrie, Mark C, Claggett, Brian L, Barlera, Simona, Cleland, John G.F, Dargie, Henry J, Granger, Christopher B, Kjekshus, John, Køber, Lars, Latini, Roberto, Maggioni, Aldo P, Packer, Milton, Pitt, Bertram, Solomon, Scott D, Swedberg, Karl, Tavazzi, Luigi, Wikstrand, John, Zannad, Faiez, Zile, Michael R, McMurray, John J.V

“…Data were analyzed from 40,195 patients with heart failure with reduced ejection fraction enrolled in 12 clinical trials in the 1995–2014 period. Sudden-death…”
Get full text

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial) by Masson, Serge, PhD, Latini, Roberto, MD, Anand, Inder S., MD, FACC, FRCP, DPhil (Oxon), Barlera, Simona, MS, Angelici, Laura, MS, Vago, Tarcisio, BiolD, Tognoni, Gianni, MD, Cohn, Jay N., MD, FACC

“…Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial) Serge Masson, Roberto Latini, Inder S…”
Get full text

Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials by Rossignol, Patrick, Masson, Serge, Barlera, Simona, Girerd, Nicolas, Castelnovo, Angelo, Zannad, Faiez, Clemenza, Francesco, Tognoni, Gianni, Anand, Inder S., Cohn, Jay N., Anker, Stefan D., Tavazzi, Luigi, Latini, Roberto

“…Aims Uncertainties remain on the biological and prognostic significance and therapeutic implications of loss in body weight (W‐LOSS) in chronic heart failure…”
Get full text

Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial by La Rovere, Maria Teresa, Pinna, Gian Domenico, Maestri, Roberto, Barlera, Simona, Bernardinangeli, Marino, Veniani, Marco, Nicolosi, Gian Luigi, Marchioli, Roberto, Tavazzi, Luigi

“…Aims To investigate the prognostic value of autonomic variables in patients with symptomatic chronic heart failure (HF) treated according to current…”
Get full text

Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels by Barbati, Elisa, Specchia, Claudia, Villella, Massimo, Rossi, Marco Luciano, Barlera, Simona, Bottazzi, Barbara, Crociati, Luisa, d'Arienzo, Carmela, Fanelli, Raffaele, Garlanda, Cecilia, Gori, Francesca, Mango, Ruggiero, Mantovani, Alberto, Merla, Giuseppe, Nicolis, Enrico B, Pietri, Silvia, Presbitero, Patrizia, Sudo, Yukio, Villella, Alessandro, Franzosi, Maria Grazia

“…PTX3 is a long pentraxin of the innate immune system produced by different cell types (mononuclear phagocytes, dendritic cells, fibroblasts and endothelial…”
Get full text

Cyclosporine A in Reperfused Myocardial Infarction by Ottani, Filippo, MD, Latini, Roberto, MD, Staszewsky, Lidia, MD, La Vecchia, Luigi, MD, Locuratolo, Nicola, MD, Sicuro, Marco, MD, Masson, Serge, PhD, Barlera, Simona, MS, Milani, Valentina, PhD, Lombardi, Mario, MD, Costalunga, Alessandra, MD, Mollichelli, Nadia, MD, Santarelli, Andrea, MD, De Cesare, Nicoletta, MD, Sganzerla, Paolo, MD, Boi, Alberto, MD, Maggioni, Aldo Pietro, MD, Limbruno, Ugo, MD

“…Abstract Background Whether cyclosporine A (CsA) has beneficial effects in reperfused myocardial infarction (MI) is debated. Objectives This study investigated…”
Get full text

Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca (GISSI-HF) trial by Finzi, Andrea A., MD, Latini, Roberto, MD, Barlera, Simona, MSc, Rossi, Maria G., MD, Ruggeri, Albarosa, MD, Mezzani, Alessandro, MD, Favero, Chiara, BSc, Franzosi, Maria G., BiolD, Serra, Domenico, MD, Lucci, Donata, MSc, Bianchini, Francesca, BSc, Bernasconi, Roberto, Maggioni, Aldo P., MD, Nicolosi, Gianluigi, MD, Porcu, Maurizio, MD, Tognoni, Gianni, MD, Tavazzi, Luigi, MD, Marchioli, Roberto, MD

“…Background The antiarrhythmic effects of n-3 polyunsaturated fatty acids (n-3PUFA) in ischemic heart disease have been demonstrated; however, studies in…”
Get full text

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial by Disertori, Marcello, Franzosi, Maria Grazia, Barlera, Simona, Cosmi, Franco, Quintarelli, Silvia, Favero, Chiara, Cappellini, Glauco, Fabbri, Gianna, Maggioni, Aldo Pietro, Staszewsky, Lidia, Moroni, Luigi Andrea, Latini, Roberto

“…Few data on the thromboembolic (TE) risk of paroxysmal and persistent atrial fibrillation (AF) are available. This study aimed to assess the incidence of TE…”
Get full text

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure by Latini, Roberto, Masson, Serge, Wong, Maylene, Barlera, Simona, Carretta, Elisa, Staszewsky, Lidia, Vago, Tarciso, Maggioni, Aldo P, Anand, Inder S, Tan, Lip B, Tognoni, Gianni, Cohn, Jay N

“…B-type natriuretic peptide is one of the most sensitive and specific biohumoral markers of heart failure. We hypothesized that B-type natriuretic peptide…”
Get more information

n-3PUFA and Holter-derived autonomic variables in patients with heart failure: Data from the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca (GISSI-HF) Holter substudy by La Rovere, Maria Teresa, MD, Staszewsky, Lidia, MD, Barlera, Simona, MSc, Maestri, Roberto, MSc, Mezzani, Alessandro, MD, Midi, Paolo, MD, Marchioli, Roberto, MD, Maggioni, Aldo P., MD, Tognoni, Gianni, MD, Tavazzi, Luigi, MD, Latini, Roberto, MD

“…Background n-3 Polyunsaturated fatty acid (n-3PUFA) supplementation in the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca…”
Get full text

Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial by Cicoira, Mariantonietta, Maggioni, Aldo Pietro, Latini, Roberto, Barlera, Simona, Carretta, Elisa, Janosi, Andras, Soler, Jordi Soler, Anand, Inder, Cohn, Jay N.

“…Aims: To assess the relationship between body mass index (BMI), mortality and mode of death in chronic heart failure (CHF) patients; to define the shape of the…”
Get full text

Systematic Review and Meta-Analysis: Renin-Angiotensin System Inhibitors in the Prevention of Atrial Fibrillation Recurrences. An Unfulfilled Hope by Disertori, Marcello, Barlera, Simona, Staszewsky, Lidia, Latini, Roberto, Quintarelli, Silvia, Franzosi, Maria Grazia

“…Purpose To analyze the published data on the role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II-receptor blockers (ARBs) in secondary…”
Get full text

Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study by Wong, Maylene, Staszewsky, Lidia, Latini, Roberto, Barlera, Simona, Volpi, Alberto, Chiang, Yann-Tong, Benza, Raymond L, Gottlieb, Sidney O, Kleemann, Thomas D, Rosconi, Franco, Vandervoort, Pieter M, Cohn, Jay N

“…The objective of the study was to evaluate the effect of an angiotensin receptor blocker on left ventricular (LV) structure and function when added to…”
Get full text

Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial by Disertori, Marcello, MD, Lombardi, Federico, MD, Barlera, Simona, MS, Maggioni, Aldo Pietro, MD, Favero, Chiara, MS, Franzosi, Maria Grazia, Biol Sci D, Lucci, Donata, MS, Staszewsky, Lidia, MD, Fabbri, Gianna, MD, Quintarelli, Silvia, MD, Bianconi, Leopoldo, MD, Latini, Roberto, MD

“…Background Atrial fibrillation (AF) is a common arrhythmia that frequently recurs after restoration of sinus rhythm. In a consistent percentage of cases, AF…”
Get full text

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial by Staszewsky, Lidia, MD, Wong, Maylene, MD, FACC, Masson, Serge, PhD, Barlera, Simona, MS, Carretta, Elisa, MS, Maggioni, Aldo P., MD, Anand, Inder S., MD, FACC, Cohn, Jay N., MD, Tognoni, Gianni, MD, Latini, Roberto, MD

“…Abstract Background Chronic obstructive pulmonary disease (COPD) and heart failure are major causes of death and disability. Because little information is…”
Get full text

Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial by Disertori, Marcello, MD, Lombardi, Federico, MD, Barlera, Simona, M Sci, Latini, Roberto, MD, Maggioni, Aldo P., MD, Zeni, Prisca, MD, Di Pasquale, Giuseppe, MD, Cosmi, Franco, MD, Franzosi, Maria Grazia, Biol Sci D

“…Background Atrial fibrillation (AF) is a common arrhythmia that frequently recurs after restoration of sinus rhythm (SR). Identifying risk factors for…”
Get full text

Clinical competence in the surgery of rectal cancer: the Italian Consensus Conference by Micaela, Piccoli, Ferdinando, Agresta, Vincenzo, Trapani, Casimiro, Nigro, Vito, Pende, Fabio Cesare, Campanile, Nereo, Vettoretto, Enrico, Belluco, Paolo, Bianchi Pietro, Davide, Cavaliere, Giuseppe, Ferulano, Filippo, La Torre, Maria, Lirici Marco, Roberto, Rea, Gianni, Ricco, Elena, Orsenigo, Simona, Barlera, Emanuele, Lettieri, Maria, Romano Giovanni

“…Background and aim The literature continues to emphasize the advantages of treating patients in “high volume” units by “expert” surgeons, but there is no…”
Get full text

Common genetic variants on chromosome 9p21 are associated with myocardial infarction and type 2 diabetes in an Italian population by Gori, Francesca, Specchia, Claudia, Pietri, Silvia, Crociati, Luisa, Barlera, Simona, Franciosi, Monica, Nicolucci, Antonio, Signorini, Stefano, Brambilla, Paolo, Franzosi, Maria Grazia

“…A genomic region on chromosome 9p21 has been identified as closely associated with increased susceptibility to coronary artery disease (CAD) and to type 2…”
Get full text

Anaesthesiological strategies in elective craniotomy: randomized, equivalence, open trial--the NeuroMorfeo trial by Citerio, Giuseppe, Franzosi, Maria Grazia, Latini, Roberto, Masson, Serge, Barlera, Simona, Guzzetti, Stefano, Pesenti, Antonio

“…Many studies have attempted to determine the "best" anaesthetic technique for neurosurgical procedures in patients without intracranial hypertension. So far,…”
Get full text

Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: Findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)–3 trial by Pedrazzini, Giovanni, MD, Santoro, Eugenio, MS, Latini, Roberto, MD, Fromm, Laurie, PharmD, Franzosi, Maria Grazia, BiolScD, Mocetti, Tiziano, MD, Staszewsky, Lidia, MD, Barlera, Simona, MS, Tognoni, Gianni, MD, Maggioni, Aldo P., MD

“…Background The causes of death occurring in clinical trials of myocardial infarction (MI) are scarcely reported in the literature. The present analysis is…”
Get full text